Navigating AI Advancements and Regulations

This chapter explores the impact of recent advancements in artificial intelligence, particularly focusing on the FDA's launch of ELSA, a generative AI tool. It addresses the benefits and challenges of AI deployment, including concerns about transparency and societal adaptation, while also delving into the dynamics of AI regulations and the balance between federal oversight and state autonomy. The discussion highlights the rapid growth of AI usage, the competitive landscape of AI chips, and the implications of proposed regulations on both innovation and security.